ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Newly discovered CRISPR mechanism may prevent dangerous errors – Phys.Org

Continue reading

2018-02-28 Michael Zand NEWS

Ophthotech (OPHT) Q4 Earnings Beat, Gene Therapy in Focus – Nasdaq

NasdaqOphthotech (OPHT) Q4 Earnings Beat, Gene Therapy in FocusNasdaqOphthotech CorporationOPHT reported loss of 26 cents per share for the fourth quarter of 2017, narrower than the Zacks Consensus Estimate of a loss of 58 cents as well as a loss of $… Continue reading

2018-02-28 Michael Zand NEWS

CAR T-cell therapy may serve as bridge to transplantation for ALL – Healio

CAR T-cell therapy may serve as bridge to transplantation for ALLHealioSALT LAKE CITY — Chimeric antigen receptor T-cell therapy may have a synergistic role with hematopoietic stem cell transplantation to improve leukemia-free survival without an incre… Continue reading

2018-02-28 Michael Zand NEWS

Editas Medicine Supports Rare Disease Day® and Joins Global Movement to Raise Important Awareness for Rare … – GlobeNewswire (press release)

Editas Medicine Supports Rare Disease Day® and Joins Global Movement to Raise Important Awareness for Rare …GlobeNewswire (press release)As a leading genome editing company, Editas Medicine is focused on translating the power and potential of the … Continue reading

2018-02-28 Michael Zand NEWS

Gene Therapy Holds Out Hope for Diabetics – PR Newswire (press release)

Gene Therapy Holds Out Hope for DiabeticsPR Newswire (press release)Since its first successful use nearly 30 years ago, gene therapy has grown into an important if experimental part of the medical sector. Now it is taking off in a big way, offering tre… Continue reading

2018-02-28 Michael Zand NEWS

Gene therapy demand drives VGXI to up Texan GMP capabilities – BioPharma-Reporter.com

BioPharma-Reporter.comGene therapy demand drives VGXI to up Texan GMP capabilitiesBioPharma-Reporter.comThe new capabilities come as a response to growing demand for gene therapy products, business development manager Christy Franco told Biopharma-Repo… Continue reading

2018-02-28 Michael Zand NEWS

Newly Identified Stem Cells Have Potential to Regenerate Blood Vessels – Pulmonary Fibrosis News

Pulmonary Fibrosis NewsNewly Identified Stem Cells Have Potential to Regenerate Blood VesselsPulmonary Fibrosis NewsA new subtype of stem cells that have the unique ability to perform two distinct functions at the same time was recently discovered by r… Continue reading

2018-02-28 Michael Zand NEWS

CAR-T cell therapy could drive a ‘revolution’ in cancer treatments – Genetic Literacy Project


Phys.Org

Newly discovered CRISPR mechanism may prevent dangerous errors
Phys.Org
In the first of two papers just published in the Journal of the American Chemical Society (JACS), researchers at The Ohio State University report that they’ve figured out the mechanism by which the CRISPR gene-editing enzyme Cas9 determines where and …
Charpentier/Doudna Patent Covering CRISPR-Cas9 Gene Regulation ApplicationsBusiness Wire (press release)
Could A More Precise CRISPR/Cas9 System Treat Huntington’s Disease?Labiotech.eu (blog)

all 3 news articles »

Continue reading

2018-02-28 Michael Zand NEWS
  • 1
  • …
  • 465
  • 466
  • 467
  • 468
  • 469
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Genetic Literacy Project

CAR–T cell therapy could drive a ‘revolution’ in cancer treatments
Genetic Literacy Project
[T]he United States Food and Drug Administration (FDA) made the landmark decision to approve two ‘drugs’ that use CAR–T cell therapy – the injection of engineered immune cells into patients – to treat blood cancers. First, in August 2017 it approved …